Both microRNA-155 and virus-encoded MiR-155 ortholog regulate TLR3 expression

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Hu, Xuming ^a   Ye, Jianqiang ^a   Qin, Aijian ^a   Zou, Haitao ^a   Shao, Hongxia ^a   Qian, Kun ^a  

^a YANGZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; MICRORNA 155; TOLL LIKE RECEPTOR 3; MICRORNA; VIRAL PROTEIN;

ANIMAL CELL; ARTICLE; BIRD; CHICK; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNE RESPONSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENETICS; METABOLISM;

AVES;

ANIMALS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; MICRORNAS; TOLL-LIKE RECEPTOR 3; VIRAL PROTEINS;

EID: 84929120971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126012     Document Type: Article

References (52)

1. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nature immunology. 2001; 2(10):947-50. Epub 2001/09/08. doi: 10.1038/ni712 PMID: 11547333.
2. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature. 2004; 430(6996):257-63. doi: 10.1038/nature02761 PMID: 15241424.
3. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 2006; 176(8):4894-901. PMID: 16585585.
4. Paone A, Starace D, Galli R, Padula F, De Cesaris P, Filippini A, et al. Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-alpha-dependent mechanism. Carcinogenesis. 2008; 29(7):1334-42. doi: 10.1093/carcin/bgn149 PMID: 18566014.
5. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, Baffi JZ, et al. Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature. 2008; 452(7187):591-7. doi: 10.1038/nature06765 PMID: 18368052; PubMed Central PMCID: PMC2642938.
6. Yates LA, Norbury CJ, Gilbert RJ. The long and short of microRNA. Cell. 2013; 153(3):516-9. doi: 10.1016/j.cell.2013.04.003 PMID: 23622238.
7. Xiao C, Rajewsky K.MicroRNA control in the immune system: basic principles. Cell. 2009; 136(1):26-36. doi: 10.1016/j.cell.2008.12.027 PMID: 19135886.
8. Quinn SR, O'Neill LA. A trio of microRNAs that control Toll-like receptor signalling. International immunology. 2011; 23(7):421-5. doi: 10.1093/intimm/dxr034 PMID: 21652514.
9. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: the fine-tuners of Toll-like receptor signalling. Nature reviews Immunology. 2011; 11(3):163-75. doi: 10.1038/nri2957 PMID: 21331081.
10. Chen XM, Splinter PL, O'Hara SP, LaRusso NF. A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. The Journal of biological chemistry. 2007; 282(39):28929-38. doi: 10.1074/jbc.M702633200 PMID: 17660297; PubMed Central PMCID: PMC2194650.
11. Benakanakere MR, Li Q, Eskan MA, Singh AV, Zhao J, Galicia JC, et al. Modulation of TLR2 protein expression by miR-105 in human oral keratinocytes. The Journal of biological chemistry. 2009; 284 (34):23107-15. doi: 10.1074/jbc.M109.013862 PMID: 19509287; PubMed Central PMCID: PMC2755716.
12. Vigorito E, Kohlhaas S, Lu D, Leyland R. miR-155: an ancient regulator of the immune system. Immunological reviews. 2013; 253(1):146-57. Epub 2013/04/05. doi: 10.1111/imr.12057 PMID: 23550644.
13. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C, Xue Y, et al. Regulation of the germinal center response by microRNA-155. Science. 2007; 316(5824):604-8. Epub 2007/04/28. doi: 10.1126/science.1141229 PMID: 17463289.
14. Rodriguez A, Vigorito E, Clare S, Warren MV, Couttet P, Soond DR, et al. Requirement of bic/micro- RNA-155 for normal immune function. Science. 2007; 316(5824):608-11. Epub 2007/04/28. doi: 10.1126/science.1139253 PMID: 17463290; PubMed Central PMCID: PMC2610435.
15. O'Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL, Chaudhuri AA, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010; 33(4):607-19. doi: 10.1016/j.immuni.2010.09.009 PMID: 20888269; PubMed Central PMCID: PMC2966521.
16. Kohlhaas S, Garden OA, Scudamore C, Turner M, Okkenhaug K, Vigorito E. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol. 2009; 182(5):2578-82. doi: 10.4049/jimmunol.0803162 PMID: 19234151.
17. Lu LF, Thai TH, Calado DP, Chaudhry A, Kubo M, Tanaka K, et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity. 2009; 30(1): 80-91. doi: 10.1016/j.immuni.2008.11.010 PMID: 19144316; PubMed Central PMCID: PMC2654249.
18. Lind EF, Elford AR, Ohashi PS. Micro-RNA 155 is required for optimal CD8+ T cell responses to acute viral and intracellular bacterial challenges. J Immunol. 2013; 190(3):1210-6. doi: 10.4049/jimmunol.1202700 PMID: 23275599.
19. Gracias DT, Stelekati E, Hope JL, Boesteanu AC, Doering TA, Norton J, et al. The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling. Nature immunology. 2013; 14(6): 593-602. doi: 10.1038/ni.2576 PMID: 23603793; PubMed Central PMCID: PMC3664306.
20. Zhou H, Huang X, Cui H, Luo X, Tang Y, Chen S, et al. miR-155 and its star-form partner miR-155∗cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood. 2010; 116(26):5885-94. Epub 2010/09/21. doi: 10.1182/blood-2010-04-280156 PMID: 20852130.
21. Gottwein E, Mukherjee N, Sachse C, Frenzel C, Majoros WH, Chi JT, et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature. 2007; 450(7172):1096-9. Epub 2007/12/14. doi: 10.1038/nature05992 PMID: 18075594; PubMed Central PMCID: PMC2614920.
22. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM, Lieberman PM. Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. Journal of virology. 2008; 82 (21):10436-43. Epub 2008/08/30. doi: 10.1128/JVI.00752-08 PMID: 18753206; PubMed Central PMCID: PMC2573162.
23. Zhao Y, Yao Y, Xu H, Lambeth L, Smith LP, Kgosana L, et al. A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus. Journal of virology. 2009; 83(1):489-92. Epub 2008/10/24. doi: 10.1128/JVI.01166-08 PMID: 18945769; PubMed Central PMCID: PMC2612317.
24. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008; 455(7216):1124-8. Epub 2008/09/23. doi: 10.1038/nature07299 PMID: 18806776.
25. Hu X, Xu W, Qin A, Wu G, Qian K, Shao H, et al. Marek's disease virus may interfere with T cell immunity by TLR3 signals. Veterinary research communications. 2014; 38(2):149-56. doi: 10.1007/s11259-014-9598-x PMID: 24585377.
26. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochimica et biophysica acta. 2009; 1792(6):497-505. Epub 2009/03/10. doi: 10.1016/j.bbadis.2009.02.013 PMID: 19268705.
27. O'Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D. MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America. 2007; 104(5):1604-9. Epub 2007/01/24. doi: 10.1073/pnas.0610731104 PMID: 17242365; PubMed Central PMCID: PMC1780072.
28. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(33):12481-6. doi: 10.1073/ pnas.0605298103 PMID: 16885212; PubMed Central PMCID: PMC1567904.
29. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis and rheumatism. 2008; 58(4):1001-9. doi: 10.1002/art.23386 PMID: 18383392.
30. Kohanbash G, Okada H. MicroRNAs and STAT interplay. Seminars in cancer biology. 2012; 22(1):70-5. doi: 10.1016/j.semcancer.2011.12.010 PMID: 22210182; PubMed Central PMCID: PMC3288787.
31. Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, Mallardo M. Epstein-Barr virus latent membrane protein1 trans-activates miR-155 transcription through the NF-kappaB pathway. Nucleic acids research. 2008; 36(20):6608-19. Epub 2008/10/23. doi: 10.1093/nar/gkn666 PMID: 18940871; PubMed Central PMCID: PMC2582607.
32. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. Journal of virology. 2010; 84(22): 11670-8. Epub 2010/09/17. doi: 10.1128/JVI.01248-10 PMID: 20844043; PubMed Central PMCID: PMC2977875.
33. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, et al. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. Journal of virology. 2007; 81(23):12836-45. Epub 2007/09/21. doi: 10.1128/JVI.01804-07 PMID: 17881434; PubMed Central PMCID: PMC2169101.
34. Zhao Y, Xu H, Yao Y, Smith LP, Kgosana L, Green J, et al. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas. PLoS pathogens. 2011; 7(2):e1001305. doi: 10.1371/journal.ppat.1001305 PMID: 21383974; PubMed Central PMCID: PMC3044692.
35. Davey GM, Wojtasiak M, Proietto AI, Carbone FR, Heath WR, Bedoui S. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo. J Immunol. 2010; 184(5):2243-6. doi: 10.4049/jimmunol.0903013 PMID: 20124105.
36. Tabiasco J, Devevre E, Rufer N, Salaun B, Cerottini JC, Speiser D, et al. Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor. J Immunol. 2006; 177(12):8708-13. PMID: 17142772.
37. Schulz O, Diebold SS, Chen M, Naslund TI, Nolte MA, Alexopoulou L, et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells. Nature. 2005; 433(7028):887-92. doi: 10.1038/nature03326 PMID: 15711573.
38. Chin AI, Miyahira AK, Covarrubias A, Teague J, Guo B, Dempsey PW, et al. Toll-like receptor 3-mediated suppression of TRAMP prostate cancer shows the critical role of type I interferons in tumor immune surveillance. Cancer research. 2010; 70(7):2595-603. doi: 10.1158/0008-5472.CAN-09-1162 PMID: 20233880; PubMed Central PMCID: PMC2995454.
39. Conforti R, Ma Y, Morel Y, Paturel C, Terme M, Viaud S, et al. Opposing effects of toll-like receptor (TLR3) signaling in tumors can be therapeutically uncoupled to optimize the anticancer efficacy of TLR3 ligands. Cancer research. 2010; 70(2):490-500. doi: 10.1158/0008-5472.CAN-09-1890 PMID: 20068181.
40. Wang T, Town T, Alexopoulou L, Anderson JF, Fikrig E, Flavell RA. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nature medicine. 2004; 10(12):1366-73. doi: 10.1038/nm1140 PMID: 15558055.
41. Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science. 2007; 317(5844):1522-7. doi: 10.1126/science.1139522 PMID: 17872438.
42. Perez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, et al. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity. 2010; 33(3):400-11. doi: 10.1016/j.immuni.2010.08.014 PMID: 20832341; PubMed Central PMCID: PMC2946444.
43. Lafaille FG, Pessach IM, Zhang SY, Ciancanelli MJ, HermanM, Abhyankar A, et al. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature. 2012; 491(7426):769-73. doi: 10.1038/nature11583 PMID: 23103873; PubMed Central PMCID: PMC3527075.
44. Taura M, Eguma A, Suico MA, Shuto T, Koga T, Komatsu K, et al. p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Molecular and cellular biology. 2008; 28(21): 6557-67. doi: 10.1128/MCB.01202-08 PMID: 18779317; PubMed Central PMCID: PMC2573237.
45. Shatz M, Menendez D, Resnick MA. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer research. 2012; 72(16):3948-57. doi: 10. 1158/0008-5472.CAN-11-4134 PMID: 22673234; PubMed Central PMCID: PMC3443562.
46. Karpala AJ, Lowenthal JW, Bean AG. Activation of the TLR3 pathway regulates IFNbeta production in chickens. Developmental and comparative immunology. 2008; 32(4):435-44. Epub 2007/09/18. doi: 10.1016/j.dci.2007.08.004 PMID: 17870162.
47. Zhang J, Zhao H, Chen J, Xia B, Jin Y, Wei W, et al. Interferon-beta-induced miR-155 inhibits osteoclast differentiation by targeting SOCS1 and MITF. FEBS letters. 2012; 586(19):3255-62. Epub 2012/07/10. doi: 10.1016/j.febslet.2012.06.047 PMID: 22771905.
48. Philippe L, Alsaleh G, Suffert G, Meyer A, Georgel P, Sibilia J, et al. TLR2 expression is regulated by microRNA miR-19 in rheumatoid fibroblast-like synoviocytes. J Immunol. 2012; 188(1):454-61. doi: 10.4049/jimmunol.1102348 PMID: 22105995.
49. Deng Y, Zhao J, Sakurai D, Kaufman KM, Edberg JC, Kimberly RP, et al. MicroRNA-3148 modulates allelic expression of toll-like receptor 7 variant associated with systemic lupus erythematosus. PLoS genetics. 2013; 9(2):e1003336. doi: 10.1371/journal.pgen.1003336 PMID: 23468661; PubMed Central PMCID: PMC3585142.
50. Forman JJ, Legesse-Miller A, Coller HA. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proceedings of the National Academy of Sciences of the United States of America. 2008; 105(39):14879-84. Epub 2008/09/25. doi: 10.1073/pnas.0803230105 PMID: 18812516; PubMed Central PMCID: PMC2567461.
51. Schnall-Levin M, Rissland OS, Johnston WK, Perrimon N, Bartel DP, Berger B. Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs. Genome research. 2011; 21(9):1395-403. Epub 2011/06/21. doi: 10.1101/gr.121210.111 PMID: 21685129; PubMed Central PMCID: PMC3166825.
52. Schnall-Levin M, Zhao Y, Perrimon N, Berger B. Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3'UTRs. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107(36):15751-6. Epub 2010/08/24. doi: 10.1073/pnas.1006172107 PMID: 20729470; PubMed Central PMCID: PMC2936641.